The key measures of a diagnostic tool include accuracy, cost per test and timeliness. The accuracy has to be high enough to make the test helpful, however, a very low cost and a fast examination time can compensate the flaw of false negative result. For example, if a single test will give a 20% false negative probability, then doing two tests will give just 4% (i.e. neither of the tests reports a positive result). Therefore, in theory, multiple tests to increase confidence of disease detection is feasible if the cost is low enough. So I believe AI in diagnostic medicine is the future and thanks to the people pushing the field so fast!
- Forums
- ASX - By Stock
- RAP
- Ann: Broker Meets Biotech Presentation
Ann: Broker Meets Biotech Presentation, page-2
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
NEWS
Antler Copper Project hits major permitting milestone – air quality permit advances to final review
NEWS
Breakthrough programs slash healthcare events, driving a significant A$1.8M+ annual revenue boost